Viewing Study NCT06922656

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-05-24 @ 5:16 AM
Study NCT ID: NCT06922656
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-29
First Post: 2025-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
Sponsor: Dasman Diabetes Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 1 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ketoacidosis View
None Hypoglycemia View
None Glucose Control View
None SGLT2 Inhibitors View
None Pioglitazone View